statistiche ricercatore

PEGHIN, MADDALENA

Distribuzione geografica

Continente	#
EU - Europa	2.661
NA - Nord America	867
AS - Asia	48
Continente sconosciuto - Info sul continente non disponibili	4
Totale	3.580

Salva come PNG Salva come JPEG

Nazione	#
IT - Italia	2.120
US - Stati Uniti d'America	865
IE - Irlanda	241
SE - Svezia	139
GB - Regno Unito	76
FI - Finlandia	55
IN - India	26
VN - Vietnam	14
UA - Ucraina	12
DE - Germania	9
EU - Europa	4
CN - Cina	3
FR - Francia	3
NL - Olanda	3
HK - Hong Kong	2
MX - Messico	2
TR - Turchia	2
CZ - Repubblica Ceca	1
ES - Italia	1
ID - Indonesia	1
PT - Portogallo	1
Totale	3.580

Salva come PNG Salva come JPEG

Città	#
Milan	1.670
Dublin	241
Ashburn	214
Rome	122
Nyköping	114
Chandler	101
Princeton	96
Washington	60
Helsinki	50
Fairfield	38
London	26
Ogden	24
Pune	24
Seattle	21
Los Angeles	14
San Diego	14
Kilburn	13
Dong Ket	12
Houston	12
Chicago	9
Jacksonville	9
Cambridge	8
Woodbridge	8
Hounslow	6
New Bedfont	6
Acton	5
Chiswick	5
Lappeenranta	5
Ann Arbor	4
Pisa	4
Redmond	4
Wilmington	4
Caserta	3
Prescot	3
Southwark	3
Wandsworth	3
Aberdeen	2
Altamura	2
Belluno	2
Berlin	2
Cologne	2
Dearborn	2
Hong Kong	2
Marcallo con Casone	2
Mexico City	2
Naples	2
New York	2
Paris	2
San Michele al Tagliamento	2
Treviso	2
Abbasanta	1
Amsterdam	1
Arezzo	1
Beijing	1
Bologna	1
Chennai	1
Council Bluffs	1
Ferrara di Monte Baldo	1
Hefei	1
Islington	1
Izmir	1
Lamezia Terme	1
Magnago	1
Maia	1
Melegnano	1
Middenmeer	1
Mineral Ridge	1
Norwalk	1
Nuremberg	1
Padova	1
Pieve di Cento	1
Rho	1
Santurtzi	1
Trieste	1
Varese	1
Totale	3.008

Salva come PNG Salva come JPEG

Nome	#
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections	107
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience	53
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis	53
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	49
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study	49
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant	49
Perioperative Antibiotic Stewardship in the Organ Transplant Setting	48
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	48
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study	48
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study	47
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization	46
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance	45
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review	43
A look at clinical trial design for new antimicrobials for the adult population	43
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections	43
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study	42
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation	42
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series	41
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis	41
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey	40
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)	40
Risk scores and surgery for infective endocarditis: in search of a good predictive score	40
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa	39
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study	39
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus	39
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection	39
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients	38
The current treatment landscape: candidiasis	38
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality	38
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis	37
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study	37
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients	37
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam	37
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia	37
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project	37
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy	37
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study	37
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe	37
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa	37
Community-acquired pneumonia: is less more?	36
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains	36
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria	36
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?	36
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study	36
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients	36
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	36
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient	35
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients	35
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014	35
Daptomycin-containing regimens for treatment of Gram-positive endocarditis	35
Treatment of Infections Due to MDR Gram-Negative Bacteria	35
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options	35
Environmental variables associated with an increased risk of invasive aspergillosis	35
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?	35
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections	35
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	34
Prevention and Treatment of Respiratory Virus Infection	34
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature	34
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam	34
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature	34
The safety of treatment options for acute bacterial skin and skin structure infections	34
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors	34
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies	34
Estimated burden of fungal infections in Italy	34
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country	34
Cystic dystrophy of the pancreas in patient with only one previous cyst	34
How to manage KPC infections	33
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study	33
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	33
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	33
The management of multidrug-resistant Enterobacteriaceae	33
New antibiotics for ventilator-associated pneumonia	33
Important new therapies for methicillin-resistant Staphylococcus aureus	33
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	32
The role of dalbavancin in skin and soft tissue infections	32
Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment	32
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19	32
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery	31
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study	31
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction	31
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study	31
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance	30
Recent concepts in fungal involvement in skin and soft tissue infections	30
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	30
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)	29
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia	29
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia	29
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	29
COVID-19 positive donor for solid organ transplantation	29
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia	28
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery	28
Italian epidemiology of Gram negative bloodstream infections over 4-year period	28
Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6	27
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience	23
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis	23
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	22
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data	22
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study	20
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors : [síntomas de salud mental un año después de la infección aguda por COVID-19: prevalencia y factores de riesgo]	17
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	16
Totale	3.610

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	29.173
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	29.173

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1	0	0	0	0	0	0	0	0	0	0	0	1
2019/2020	13	0	0	0	1	0	2	1	1	0	6	0	2
2020/2021	64	1	9	1	4	1	6	5	5	6	4	4	18
2021/2022	219	0	1	0	1	2	2	0	0	112	22	2	77
2022/2023	628	48	3	7	75	44	209	2	85	94	29	16	16
2023/2024	2.746	386	446	421	537	610	200	35	47	45	17	2	0
Totale													3.673